182 related articles for article (PubMed ID: 30036514)
1. Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.
Bass R; Fleshner N; Finelli A; Barkin J; Zhang L; Klotz L
J Urol; 2019 Jan; 201(1):113-119. PubMed ID: 30036514
[TBL] [Abstract][Full Text] [Related]
2. Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.
Bass R; Fleshner N; Finelli A; Barkin J; Zhang L; Klotz L
J Urol; 2019 Jan; 201(1):113-119. PubMed ID: 30577402
[TBL] [Abstract][Full Text] [Related]
3. Primary whole-gland ablation for localized prostate cancer with high-intensity focused ultrasound: The important predictors of biochemical recurrence.
Chen PY; Chiang PH; Liu YY; Chuang YC; Cheng YT
Int J Urol; 2018 Jun; 25(6):615-620. PubMed ID: 29756298
[TBL] [Abstract][Full Text] [Related]
4. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
5. High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical Trial.
Jones TA; Chin J; Mcleod D; Barkin J; Pantuck A; Marks LS
J Urol; 2018 Jan; 199(1):133-139. PubMed ID: 28652121
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes.
Garcia-Barreras S; Sanchez-Salas R; Sivaraman A; Barret E; Secin F; Nunes-Silva I; Linares-Espinós E; Rozet F; Galiano M; Cathelineau X
J Urol; 2018 Jan; 199(1):140-146. PubMed ID: 28823768
[TBL] [Abstract][Full Text] [Related]
7. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
8. Pathological, Oncologic and Functional Outcomes of a Prospective Registry of Salvage High Intensity Focused Ultrasound Ablation for Radiorecurrent Prostate Cancer.
Siddiqui KM; Billia M; Arifin A; Li F; Violette P; Chin JL
J Urol; 2017 Jan; 197(1):97-102. PubMed ID: 27422297
[TBL] [Abstract][Full Text] [Related]
9. Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound.
Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
J Urol; 2020 Apr; 203(4):734-742. PubMed ID: 31928408
[TBL] [Abstract][Full Text] [Related]
10. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
11. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
[TBL] [Abstract][Full Text] [Related]
12. Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused Ultrasound.
Mortezavi A; Krauter J; Gu A; Sonderer J; Bruhin J; Reeve KA; Held L; Donati OF; Rupp NJ; Moch H; Sulser T; Eberli D
J Urol; 2019 Oct; 202(4):717-724. PubMed ID: 31042109
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of proton magnetic resonance spectroscopy in predicting positive biopsy after high-intensity focused ultrasound for treatment of localized prostate cancer.
Muto S; Kaminaga T; Horiuchi A; Kitamura K; Saito K; Isotani S; Yamaguchi R; Ide H; Furui S; Horie S
Int J Urol; 2014 Aug; 21(8):776-80. PubMed ID: 24650235
[TBL] [Abstract][Full Text] [Related]
14. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
15. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of Focal High Intensity Focused Ultrasound for Localized Prostate Cancer.
Nahar B; Bhat A; Reis IM; Soodana-Prakash N; Becerra MF; Lopategui D; Venkatramani V; Patel R; Madhusoodanan V; Kryvenko ON; Ritch CR; Gonzalgo ML; Punnen S; Parekh DJ
J Urol; 2020 Sep; 204(3):483-489. PubMed ID: 32167866
[TBL] [Abstract][Full Text] [Related]
17. Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes.
Komura K; Inamoto T; Masuda H; Watsuji T; Azuma H
Acta Biomed; 2012 Dec; 83(3):189-96. PubMed ID: 23762994
[TBL] [Abstract][Full Text] [Related]
18. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
Inoue Y; Goto K; Hayashi T; Hayashi M
Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
[TBL] [Abstract][Full Text] [Related]
19. Partial Gland Treatment of Prostate Cancer Using High-Intensity Focused Ultrasound in the Primary and Salvage Settings: A Systematic Review.
Golan R; Bernstein AN; McClure TD; Sedrakyan A; Patel NA; Parekh DJ; Marks LS; Hu JC
J Urol; 2017 Nov; 198(5):1000-1009. PubMed ID: 28433640
[TBL] [Abstract][Full Text] [Related]
20. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
